Navigation Links
Micromet Highlights Clinical Plans and Regulatory Strategy for Lead Product Candidate Blinatumomab at its Annual R&D Day
Date:2/10/2010

atumomab in pediatric ALL – Based on experience from compassionate use utilization of blinatumomab in pediatric patients with relapsed/refractory ALL, the efficacy results in adult ALL and preliminary discussions with the EMEA, the Company is in the process of designing studies to facilitate expedited development of blinatumomab in this setting. The Company expects to finalize discussions with FDA and EMEA regarding its registration strategy in pediatric ALL during the course of 2010.

"Children resistant to available treatments for ALL are in dire need of new therapeutic options," said Arend von Stackelberg, M.D., Pediatric Oncology/Hemotology, Charite - University Clinic, Berlin, Germany.  "The experience to date with blinatumomab in ALL is very encouraging and provides a strong rationale for expanded development in the pediatric setting."

  • Phase 2 study in relapsed/refractory adult ALL – The Company plans to initiate an exploratory Phase 2 single-arm study in adult patients with relapsed/refractory ALL.  The primary endpoint of the study is hematological complete response rate.  The Company currently expects to initiate the study in mid-2010.

"Many adults with ALL who achieve complete remission will eventually relapse, making prevention of recurrence the best strategy for long-term patient survival," said Deborah Thomas, M.D., Associate Professor, Department of Leukemia, MD Anderson Cancer Center, Houston, Texas.  "Novel therapeutic approaches for the treatment of this disease are therefore desperately needed."

  • Phase 2 study in relapsed/refractory Chronic Lymphocytic Leukemia (CLL) – In collaboration with leading investigator
    '/>"/>

SOURCE Micromet, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Final Data from Phase 2 Study Confirm High Response Rate of Micromets Blinatumomab in Patients with Acute Lymphoblastic Leukemia
2. Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet
3. Micromet to Present at The 8th Annual BIO Investor Forum Conference on October 29, 2009
4. Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients
5. Micromet Presents Update on Blinatumomabs Response Rate and Duration in a Phase 1 Study in Non-Hodgkins Lymphoma Patients
6. Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day
7. Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells
8. Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203
9. Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
10. Micromet Key Events for 2009
11. Micromet Expands Committed Equity Financing Facility to $75 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 BioLight ... BLGTY) ("BioLight" or the "Company"), a firm that ... ophthalmology and cancer diagnostics, today announced that its ... identified several new genetic markers with high potential ... treated with bisphosphonate drugs and was able to ...
(Date:8/31/2015)... Premune and Innovet ... licensing agreement for Redonyl ® Ultra. The product, ... veterinary dermatology market, is a nutritional supplement based on ... in dogs and cats. Redonyl ® Ultra is ... has been received positively in the country by veterinarians ...
(Date:8/31/2015)... DUBLIN , Aug. 31, 2015 ... the addition of the "Prescription Pain Drugs ... Medical Marijuana - Global Markets, Competitors and Opportunities: ... to their offering. Pain is ... associated with actual or potential tissue damage. At ...
Breaking Medicine Technology:BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3
(Date:8/31/2015)... ... 2015 , ... The dental implant and prosthetic market in the U.S. is ... (See Press Room ) More than 30 million Americans are missing all their ... demand for dental implants, the National Association of Dental Laboratories (NADL) created the “What’s ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... psychology professor Luciana Lagana (aka Dr. Luciana) received a total of three ... Series, Best Documentary, and Best (Dis)ability Film. Dr. Luciana co-wrote and co-produced this ...
(Date:8/31/2015)... ... 2015 , ... People with hostile personality traits who watch ... potentially because they are more susceptible to the influence of television on violence ... discovered. , The research, published online in the International Journal of Injury ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Month 2015 in September by sharing the facts about the role of heredity ... and BRCA2 genetic mutations because of Angelina Jolie Pitt’s decisions to have both ...
(Date:8/31/2015)... ... August 31, 2015 , ... Move over shave cream. Roll over ... barbershops are scrambling to meet it. , Reports published this year (Mintel data) announced ... But the data also reflects that men are getting more done at barbershops than ...
Breaking Medicine News(10 mins):Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4Health News:Actor/Writer/Director/Psychology Professor Luciana Lagana Receives Three Wins at the 2015 Global Independent Film Awards for the TV Pilot Dr. Luciana on Aging and Falling 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 4Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 2Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 3
... announces the launch of their new website www.GlaceComplete.com . ... to Glenwood Systems and the company,s turbo-charged practice management/billing system GlaceComplete ... information. , ... Waterbury, CT (PRWEB) January Monday 12, ...
... the popular salve used to relieve symptoms of cough ... New research appearing in the January issue of ... of Chest Physicians (ACCP), shows that Vicks VapoRub (VVR) ... have severe effects on breathing in an infant or ...
... QLT and Upholds District Court DecisionVANCOUVER, Jan. 12 /PRNewswire-FirstCall/ ... QLT) announced that the United States Court of Appeals ... affirmed the judgment of the United States District Court ... the lawsuit brought against QLT by Massachusetts Eye and ...
... Patient, Provider and Industry Groups Calls for CER ... of Health CareWASHINGTON, Jan. 12 Federally-supported comparative ... improve health care decision-making, and must be structured ... provider needs, according to the Partnership to Improve ...
... of the widely used guideline , , MONDAY, Jan. 12 (HealthDay News) ... who have a low 10-year risk of heart attack or stroke ... a high lifetime risk. , That,s the conclusion of a new ... It,s the third study published in the last week to question ...
... (NYSE: DGX ), the world,s leading provider ... it will report fourth-quarter and full year 2008 results ... 26, before the market opens. It will hold its ... beginning at 8:30 a.m. ET on that day.The public ...
Cached Medicine News:Health News:Glenwood Systems, LLC Launches New Website -- GlaceComplete.com 2Health News:Misuse of Vicks VapoRub may harm infants and toddlers 2Health News:Misuse of Vicks VapoRub may harm infants and toddlers 3Health News:QLT Announces Appeal Court Decision on Massachusetts Eye and Ear Infirmary Litigation 2Health News:QLT Announces Appeal Court Decision on Massachusetts Eye and Ear Infirmary Litigation 3Health News:PIPC Outlines CER Principles in Letter to President-Elect Obama 2Health News:PIPC Outlines CER Principles in Letter to President-Elect Obama 3Health News:PIPC Outlines CER Principles in Letter to President-Elect Obama 4Health News:Framingham Score May Not Spot Lifetime Heart Risk 2Health News:Framingham Score May Not Spot Lifetime Heart Risk 3Health News:Quest Diagnostics to Release Fourth Quarter and Full Year 2008 Financial Results 2
Silicone Elastomer-Coated Latex Foley Catheters 2-Way (Pediatric)...
Midstream Catch Kits...
Midstream Catch Kits...
... BVM 6500 enables physicians ... determine UEBW (ultrasound estimated ... volume using 3-dimensional V-mode ... was designed to assist ...
Medicine Products: